IQVIA is a global provider of data, technology, and human science services for the life sciences industry, serving pharmaceutical manufacturers, emerging biopharma, MedTech, and other healthcare organizations. The company combines healthcare-grade AI with clinical expertise to help clients accelerate innovation, improve patient outcomes, and bring treatments to market faster.
IQVIA operates across the Americas, Europe, Asia and Oceania, and the Middle East and Africa, offering regional thought leadership and localized support. Its solutions span research and development, commercialization, real-world evidence, safety and regulatory compliance, patient centricity, and technologies. This breadth allows organizations to address challenges across the product lifecycle, from early-phase clinical development to post-market surveillance.
IQVIA AI includes the Field Force Agent, an AI-powered assistant that helps life sciences field teams plan and execute high-impact, compliant HCP engagements by delivering real-time insights. This tool is designed to support commercial teams in making data-driven decisions while maintaining regulatory compliance. The platform reflects IQVIA's broader investment in applying AI to healthcare-specific problems.
The IQVIA NLP Platform transforms unstructured text into structured information and metadata, enabling users across the product lifecycle to search and enrich documents at enterprise scale. According to IQVIA, combining healthcare-grade AI with clinical expertise can transform and expedite medical record review by 10x-100x, maximizing efficiencies across teams. One customer reported that spending a couple of hours with IQVIA NLP saved around $40,000 by avoiding a project with a negative outcome.
IQVIA's therapeutic and specialty centers of excellence provide scientific expertise, therapeutic insights, and clinical trial experience to expedite new therapies for patients. Areas of focus include allergy and respiratory, biosimilars, cardiovascular, cell and gene therapy, central nervous system, dermatology, endocrinology, GI and hepatology, infectious diseases and vaccines, and reproductive health. This specialization supports study delivery through teams of specialists providing input, training, and insights from beginning to end.
IQVIA serves a range of life science segments, including consumer health, emerging biopharma, generics, MedTech, and pharmaceutical manufacturers. It also works with healthcare segments such as information partner services, financial institutions, global health, government, patient associations, payers, and providers. The company applies its data and analytics expertise to enable health equity and SDOH strategies and plans, helping organizations address disparities in care.
As a global community, IQVIA continuously invests and commits to advancing human health. Its work supports clients in improving patient outcomes and bringing treatments to market faster. By combining data, technology, and human science, IQVIA aims to address some of the most pressing challenges in healthcare.